the effects of artesunate on the expression of egfr and abcg2 in a549 human lung cancer cells and a xenograft model青蒿琥酯的影响对表皮生长因子受体的表达和abcg2在人类肺癌细胞a549和异种移植模型.pdfVIP

下载本文档

2
0
约4.31万字
约 14页
2017-09-12 发布于上海
举报
版权申诉

the effects of artesunate on the expression of egfr and abcg2 in a549 human lung cancer cells and a xenograft model青蒿琥酯的影响对表皮生长因子受体的表达和abcg2在人类肺癌细胞a549和异种移植模型.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

the effects of artesunate on the expression of egfr and abcg2 in a549 human lung cancer cells and a xenograft model青蒿琥酯的影响对表皮生长因子受体的表达和abcg2在人类肺癌细胞a549和异种移植模型

Molecules 2011, 16, 10556-10569; doi:10.3390/molecules161210556 OPEN ACCESS molecules ISSN 1420-3049 /journal/molecules Article The Effects of Artesunate on the Expression of EGFR and ABCG2 in A549 Human Lung Cancer Cells and a Xenograft Model Hu Ma 1,2, Quan Yao 1, An-Mei Zhang 1, Sheng Lin 1, Xin-Xin Wang 1, Lei Wu 1, Jian-Guo Sun 1,* and Zheng-Tang Chen 1,* 1 Cancer Institute of PLA, Xinqiao Hospital, Third Military Medical University, Xinqiao Street No. 2, Chongqing 400037, China 2 Department of Oncology, Affiliated Hospital of Zunyi Medical College, Zunyi 563000, China * Authors to whom correspondence should be addressed; E-Mails: sunjg09@ (J.-G.S.); chenztang@ (Z.-T.C.); Tel.: +86-23-6875-5626. Received: 31 October 2011; in revised form: 25 November 2011 / Accepted: 5 December 2011 / Published: 19 December 2011 Abstract: Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Clinical and laboratory studies have suggested that multi-targeting approaches against neoplastic cells could help to increase patient survival and might reduce the emergence of cells that are resistant to single-target inhibitors. Artesunate (ART) is one of the most potent and rapidly acting antimalarial agents known, and it also exerts a profound cytotoxic activity toward cancer cells and reverses multi-drug resistance. In the present study, we found that artesunate inhibited NSCLC A549 cell growth and proliferation, induced apoptosis and suppressed tu